Phaverso SRL
5.4 FTEThe score of Phaverso shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +35 % Total assets +15 % Headcount (avg FTE) +42 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Phaverso's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 28 Jul 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 20 Jul 2023
- Year ended 31 Dec 2021filed on 06 Jul 2022
Phaverso's financial analysis
- Solvency54.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Phaverso
Phaverso's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0875.327.505
- VAT number
- BE0875327505
- Peppol
- Registered · 0208:0875327505 · as of 01 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Jul 2005
- Registered office
- 8890 Moorslede
- Size
- Micro · 5.4 FTE
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Phaverso (SRL) has been based in Moorslede since 2005, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 327,651 € and equity of €1.79m; its revenue is not published. With 5.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 54.6%, above the median of its sector (44.2%).
Companies similar to Phaverso
Companies in the same business, of comparable size and area, outside its group.
- Romapharm Retail sale of pharmaceutical products Koksijde · balance sheet €2.97m
- Unidose Pharma Retail sale of pharmaceutical products Izegem · balance sheet €3.90m
- Apotheek An Sofie Stragier Retail sale of pharmaceutical products Bruges · balance sheet €2.66m
- Apotheekgroep Zele Retail sale of pharmaceutical products Zele · balance sheet €3.55m
- Pharmalorraine Retail sale of pharmaceutical products Aubange · balance sheet €2.26m
- Molleman - DE Coster Retail sale of pharmaceutical products Wingene · balance sheet €2.22m
- LES Pharmacies Rurales Retail sale of pharmaceutical products Celles (lez-Tournai) · balance sheet €5.91m
- PharmaOPS.BXL Retail sale of pharmaceutical products Brussels · balance sheet €3.56m
Frequently asked questions about Phaverso
What is the revenue of Phaverso?
Phaverso files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Phaverso?
In Belgium, the VAT number is the company number prefixed with BE: BE0875327505 for Phaverso, if the company is VAT-registered. Its company number (CBE) is 0875.327.505.
Where is the registered office of Phaverso?
According to the CBE register, the registered office of Phaverso is in 8890 Moorslede.
What is the equity of Phaverso?
At the close of the 2025 financial year, the equity of Phaverso amounts to 1,793,270 €, a solvency of 54.6% of total assets.
How many people work at Phaverso?
5.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Phaverso?
The register lists 1 active mandates at Phaverso. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Phaverso
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →